Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HCFA Draft List Of Device Categories Under OPPS Meets Industry Approval

This article was originally published in The Gray Sheet

Executive Summary

Six categories of stents are included in the Health Care Financing Administration's proposed list of device "pass-through" payment categories under the Medicare hospital outpatient prospective payment system (OPPS).

You may also be interested in...



Scully Nominated As HCFA Chief, Will Develop OPPS New Category Criteria

Establishing criteria to use in the creation of additional "pass-through" device categories for HCFA's outpatient prospective payment system (OPPS) will be one of the initial tasks facing incoming agency administrator Thomas Scully, currently President and CEO of the Federation of American Hospitals.

Scully Nominated As HCFA Chief, Will Develop OPPS New Category Criteria

Establishing criteria to use in the creation of additional "pass-through" device categories for HCFA's outpatient prospective payment system (OPPS) will be one of the initial tasks facing incoming agency administrator Thomas Scully, currently President and CEO of the Federation of American Hospitals.

OPPS Categories Should Be Distinct Enough To Allow Additions - AdvaMed

The range of products in each of the Health Care Financing Administration's device hospital outpatient prospective payment system (OPPS) "pass-through" categories should not be so broad as to prevent the development of new categories in the future, according to AdvaMed.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014496

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel